NOVARTIS CAP P Profile

66989HAF5   84.95  2.56  3.11%   

Performance

Good

 
Weak
 
Strong

Odds Of Default

Below Average

 
High
 
Low
NOVARTIS CAP CORP 3.7 percent 21Sep2042 is a Senior Unsecured Note issued by the corporate entity on the 18th of September 2012. NOVARTIS is trading at 84.95 as of the 20th of March 2025, a 3.11% up since the beginning of the trading day. The bond's open price was 82.39. NOVARTIS has about a 31 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Ratings for NOVARTIS CAP P are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.

Moving against NOVARTIS Bond

  0.84AXSM Axsome TherapeuticsPairCorr
  0.73CBYDF Corby SpiritPairCorr
  0.71NVRO Nevro CorpPairCorr
  0.7FWEDF Fireweed ZincPairCorr
  0.68JSEAX Jpmorgan InternationalPairCorr
  0.67TCTZF Tencent Holdings Downward RallyPairCorr

NOVARTIS Bond Highlights

Business ConcentrationNOVARTIS CAP P Corporate Bond, Financial, Financial Services (View all Sectors)
Sub Product AssetCORP
Coupon Payment FrequencySemi-Annual
CallableYes
Sub Product Asset TypeCorporate Bond
NameNOVARTIS CAP CORP 3.7 percent 21Sep2042
C U S I P66989HAF5
Offering Date18th of September 2012
Coupon3.7
Debt TypeSenior Unsecured Note
I S I NUS66989HAF55
Issuer CountrySwitzerland
Yield To Maturity5.572
Price78.25
NOVARTIS CAP P (66989HAF5) is traded in USA.

NOVARTIS CAP P Risk Profiles

NOVARTIS Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in NOVARTIS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Other Information on Investing in NOVARTIS Bond

NOVARTIS financial ratios help investors to determine whether NOVARTIS Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVARTIS with respect to the benefits of owning NOVARTIS security.